Skip to main content
Clinical Trials/JPRN-UMIN000012538
JPRN-UMIN000012538Completed未知

Effect of high-dose angiotensin II receptor blocker (ARB) monotherapy versus combination therapy of ARB with calcium channel blocker on vascular endothelial function in patients with essential hypertenson - Effect of high-dose ARB monotherapy versus combination therapy of ARB with CCB on vascular endothelial function in patients with essential hypertenson

Osaka Medical College0 sites40 target enrollmentStarted: December 10, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. History of ischemic heart disease 2. History of cerebrovascular disease 3. patients with renal dysfunction(serum creatinine greater than 1.5mg/dL) 4. patients with diabetes who are poor blood sugar control(HbA1c greater than8.0%) 5. By the change of antihypertensive drugs, blood pressure instability is suspected. 6. patients who takes high-dose ARB

Investigators

Similar Trials